Trust Still Owes Tax After $191 Million Pharma Stock Settlement
The former shareholder of a pharmaceutical business owes additional tax on a portion of its $191 million settlement payout following a squeeze-out merger, after the Third Circuit determined Thursday that the shareholder couldn’t convert what was ordinary income into capital gains.



